Johnson & Johnson Vision News
Print this Article | Send to Colleague
Johnson & Johnson Vision News
Johnson & Johnson Vision Expands Access to Myopia Management for More Patients with Abiliti™ Overnight Lenses
Johnson & Johnson Vision,1 recently announced FDA approval of an expanded range of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management, now up to 6.00 diopters (previously 4.00 diopters).
Myopia is a chronic and progressive disease that poses the biggest eye health threat of the 21st Century.2,i,i,iii Children under 12 who are diagnosed with myopia are at greater risk of developing high myopia, which may lead to sight threatening complications later in life.iv
Abiliti™ Overnight lenses are orthokeratology (ortho-k) lenses and are worn overnight to temporarily reduce refractive error and subject to an eye care professional’s myopia management plan, may eliminate the need to wear contact lenses or glasses during waking hours after the lenses are removed.2v The lenses are designed to match a patient’s eye based on its unique corneal shape and prescription.vi The FitAbiliti™ software guides the eye care professional through the fitting process empirically and recommends a lens with the first fit success rate of approximately 90%.*1
Abiliti™ Overnight Therapeutic Lenses for Myopia Management are now available nationwide. The lenses are available in two different lens designs: ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management and ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management for Astigmatism.7
Patients and eye care professionals seeking more information can visit: www.seeyourabiliti.com.
1 Flitcroft DI et al. IMI–Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60:M20-30.
1 Donovan L, Sankaridurg P, Ho A et al. Myopia progression rates in urban children wearing single-vision spectacles. OVS 2012;89(1):27-32.
1 Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic – A Worldwide Economic and Social Model. Invest Ophthalmol Vis Sci.2019;60(9):5466-5466.
1 Hu Y, Ding X, Guo X, Chen Y, Zhang J, He M. Association of Age at Myopia Onset with Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort. Jama Ophthalmol. 2020;138(11):1129-1134. doi:10.1001/jamaophthalmol.2020.3451.
1 Data on File 2022. Instruction for Use.
1 Data on File 2021. Menicon Design History File.
1 Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
1 For the purposes of refractive correction, the lenses are indicated for reducing error up to 6.00D of myopia and up to 1.50D of astigmatism. Results may vary by patient and prescription level.
* Final lens fit is determined by the ECP - software is for decision support only
†Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
1 Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
2 For the purposes of refractive correction, the lenses are indicated for reducing error up to 6.00D of myopia and up to 1.50D of astigmatism. Results may vary by patient and prescription level.
* Final lens fit is determined by the ECP - software is for decision support only
†Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
